Success! You're on the list.

Success! You're on the list.

German medtech startup CUREosity raises €3.8M for VR therapy system

CUREosity funding
Picture credits: CUREosity

Düsseldorf, Germany-based CUREosity, a medtech startup, has secured €3.8 million in growth financing. The round saw participation from existing investor Aachen-based TechVision Fund (TVF) that invested in LiSA and the Belgian family office Nomainvest alongside other new co-investors. The growth financing round also received support from the law firms ADVANT Beiten and Forvis Mazars.

The latest funding round will enable CUREosity to further advance its innovative solutions and expand its market presence. The capital will be used, among other things, to further expand CUREO®’s market leadership in the field of VR therapy.

Björn Lang, Partner at TVF said, “CUREOSITY solves the problem of the shortage of skilled workers in the field of therapy. Especially due to demographic change, smart solutions like CUREO are highly relevant to society. We look forward to participating in the solutions and successes in the future.”

Idea behind CUREosity

The German startup was founded by Thomas Saur, Stefan Arand, and Marco Faulhammer. After a car accident in 2000, Thomas Saur’s infant son suffered from paraplegia. When searching for the best available care and rehabilitation, existing methods did not achieve the desired progress.

The other two co-founders of CUREOSITY also experienced similar fates and challenges, which led them to the decision, to develop a new form of therapy that combines their therapeutic experiences and learnings with current technologies and neuroscientific findings.

Through many years of experience in 3D visualisation and the creation of application concepts in the IT and science sectors of working in this field, the founders bring profound technical know-how to the table. The combination of their technical skills, their expertise in 3D visualisation, their experiences with Virtual Reality, and their motivation from their own or their family’s medical sufferings, has led to the foundation of CUREOSITY and the idea for CUREO.

What is CUREO?

The company has launched its virtual reality therapy (VR therapy) CUREO®, which is now in use in nearly 200 therapeutic facilities. The software is now used in 24 countries worldwide. CUREO® is an efficient and effective therapy system with an enormous variety of applications. It can be used in groups or parallel, to relieve your staff and deliver more therapy to the patients. 

As per the company, this offering is touted to have helped 84% of stroke patients show clinically relevant progress, and 95% of patients are said to be motivated to continue their therapy. 

Caesar van Heyningen, CEO of CUREosity, said, “The current successful course – consisting of scaling markets and high-quality updates of our therapy software – is strengthened by this financing. We plan to invest heavily in commercial expansion, incorporating tomorrow’s technological possibilities into our product roadmap today. With this financing round, we can ensure financial independence and sustainable business operations. A privilege – especially in tight market conditions.”

Related Posts

Get daily funding news briefings in the tech world delivered right to your inbox.

Enter Your Email
join our newsletter. thank you